Primary Open Angle Glaucoma (POAG) Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Primary Open Angle Glaucoma (POAG) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract

CataractPrimary Open Angle Glaucoma (POAG)
Military Institute od Medicine National Research Institute40 enrolled2 locationsNCT07462000
Recruiting

UBM Evaluation After Combined Deep Sclerectomy With Trabeculotomy in Primary Open Angle Glaucoma

Primary Open Angle Glaucoma (POAG)
Minia University Hospital30 enrolled1 locationNCT07454447
Recruiting
Not Applicable

Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma

GlaucomaPrimary Open Angle Glaucoma (POAG)Neuroprotection
Institut Catala de Retina108 enrolled2 locationsNCT07322965
Recruiting
Phase 3

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular HypertensionPrimary Open Angle Glaucoma (POAG)
Huons Co., Ltd.206 enrolled1 locationNCT07335211
Recruiting
Phase 1Phase 2

GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma

Primary Open Angle Glaucoma (POAG)
IVIEW Therapeutics Inc.12 enrolled1 locationNCT06921317
Recruiting
Not Applicable

Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma

Primary Open Angle Glaucoma (POAG)
Select Eye Care60 enrolled1 locationNCT07147647
Recruiting

A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma

Primary Open Angle Glaucoma (POAG)
Iantrek, Inc.200 enrolled2 locationsNCT06615661
Recruiting
Phase 4

A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma

Open Angle GlaucomaGlaucomaPrimary Open Angle Glaucoma (POAG)
Glostrup University Hospital, Copenhagen126 enrolled1 locationNCT06792422